| Literature DB >> 13679171 |
I Cacciatore1, A M Caccuri, A Di Stefano, G Luisi, M Nalli, F Pinnen, G Ricci, P Sozio.
Abstract
The new GSH analogues H-Glo(-Ser-Gly-OH)-OH (5), its O-benzyl derivative 4, and H-Glo(-Asp-Gly-OH)-OH (9), characterized by the replacement of central cysteine with either serine or aspartic acid, and containing an urethanic fragment as isosteric substitution of the scissile gamma-glutamylic junction, have been synthesized and characterized. Their ability to inhibit human GST P1-1 (hGST P1-1) in comparison with H-Glu(-Ser-Gly-OH)-OH and H-Glu(-Asp-Gly-OH)-OH, which are potent competitive inhibitors of rat GST 3-3 and 4-4, has been evaluated. In order to further investigate the effect of the isosteric substitution on the binding abilities of the new GSH analogues 4, 5 and 9, the previously reported cysteinyl-containing analogue H-Glo(-Cys-Gly-OH)-OH has been also evaluated as a co-substrate for hGSTP1-1.Entities:
Mesh:
Substances:
Year: 2003 PMID: 13679171 DOI: 10.1016/S0014-827X(03)00135-6
Source DB: PubMed Journal: Farmaco ISSN: 0014-827X